Literature DB >> 15527760

The novel gene fad104, containing a fibronectin type III domain, has a significant role in adipogenesis.

Kei Tominaga1, Chiharu Kondo, Yoshikazu Johmura, Makoto Nishizuka, Masayoshi Imagawa.   

Abstract

A novel gene named fad104 (factor for adipocyte differentiation-104), whose expression level quickly increased in the early stage of adipogenesis, was isolated and characterized. The deduced amino acid sequence of fad104 revealed the possible presence of a fibronectin type III domain and transmembrane domain. The expression of fad104 was detected in adipocyte differentiable 3T3-L1 cells but not observed in the non-adipogenic cell line NIH-3T3. Moreover, the ability of 3T3-L1 cells to differentiate declined with the knockdown of fad104 by RNA interference, strongly indicating that fad104 functions as a positive regulator of adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527760     DOI: 10.1016/j.febslet.2004.09.062

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Role of volume-regulated and calcium-activated anion channels in cell volume homeostasis, cancer and drug resistance.

Authors:  Else K Hoffmann; Belinda H Sørensen; Daniel P R Sauter; Ian H Lambert
Journal:  Channels (Austin)       Date:  2015-11-16       Impact factor: 2.581

2.  Miles to go (mtgo) encodes FNDC3 proteins that interact with the chaperonin subunit CCT3 and are required for NMJ branching and growth in Drosophila.

Authors:  Adeela Syed; Tamás Lukacsovich; Miles Pomeroy; A Jane Bardwell; Gentry Thomas Decker; Katrina G Waymire; Judith Purcell; Weijian Huang; James Gui; Emily M Padilla; Cindy Park; Antor Paul; Thai Bin T Pham; Yanete Rodriguez; Stephen Wei; Shane Worthge; Ronak Zebarjedi; Bing Zhang; Lee Bardwell; J Lawrence Marsh; Grant R MacGregor
Journal:  Dev Biol       Date:  2018-10-25       Impact factor: 3.582

3.  FAD104, a regulatory factor of adipogenesis, acts as a novel regulator of calvarial bone formation.

Authors:  Keishi Kishimoto; Makoto Nishizuka; Daiki Katoh; Ayumi Kato; Shigehiro Osada; Masayoshi Imagawa
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

4.  FNDC3A is required for adhesion between spermatids and Sertoli cells.

Authors:  Kevin L Obholz; Arsen Akopyan; Katrina G Waymire; Grant R MacGregor
Journal:  Dev Biol       Date:  2006-07-08       Impact factor: 3.582

5.  Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B.

Authors:  Chunlin Cai; Megha Rajaram; Xin Zhou; Qing Liu; John Marchica; Jinyu Li; R Scott Powers
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

6.  Principal-component-based multivariate regression for genetic association studies of metabolic syndrome components.

Authors:  Hao Mei; Wei Chen; Andrew Dellinger; Jiang He; Meng Wang; Canddy Yau; Sathanur R Srinivasan; Gerald S Berenson
Journal:  BMC Genet       Date:  2010-11-09       Impact factor: 2.797

Review 7.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

8.  Neutrophil gelatinase-associated lipocalin protects renal tubular epithelial cells in hypoxia-reperfusion by reducing apoptosis.

Authors:  Xiujuan Zang; Feng Zheng; Hai-juan Hong; Yan Jiang; Ying Song; Yanping Xia
Journal:  Int Urol Nephrol       Date:  2014-06-28       Impact factor: 2.370

9.  Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity.

Authors:  Daiki Katoh; Makoto Nishizuka; Shigehiro Osada; Masayoshi Imagawa
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

10.  Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway.

Authors:  Hao-Jie Zhang; Jing Tao; Lu Sheng; Xin Hu; Rui-Ming Rong; Ming Xu; Tong-Yu Zhu
Journal:  Onco Targets Ther       Date:  2016-03-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.